Search Results 241-250 of 16351 for anti-TNF drugs

1. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... TNF inhibitors within 2-8 weeks of or 5 half-lives (etanercept ...

2. Alzheimer's treatments: What's on the horizon? - Mayo Clinic

   The medicines prevent amyloid plaques in the brain from clumping. Lecanemab is given as an IV infusion every two weeks. Your care team likely will watch for ...

3. Tocilizumab-anoh (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Tocilizumab-anoh injection is used alone or together with other medicines to treat moderate to severe active rheumatoid arthritis in patients who have been ...

4. Phase IIa Study Evaluating AZD7798 in Crohn's Disease (AMALTHEA) - Mayo Clinic

   Any biologic targeting immune response other than an anti-TNF within 12 weeks prior to screening endoscopy visit; Other advanced small molecule treatments ...

5. Sulfasalazine (oral route) - Side effects & dosage - Mayo Clinic

   ... drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the ...

6. Publications - Afsaneh Alavi, M.D. - Mayo Clinic

   Therapeutic drug monitoring in hidradenitis suppurativa patients on adalimumab: A retrospective cohort. J Am Acad Dermatol. 2025 Aug; 93 (2):516-518 Epub ...

7. Ustekinumab-aekn (subcutaneous route) - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Drugs & Supplements A-Z · Health ... Is naïve to biologic therapy (TNF antagonists or vedolizumab) ... anti-tumor necrosis factors (TNFs) for at least 8 weeks.

9. Publications - James P. Utz, M.D. - Mayo Clinic

   Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med. 2008 Nov 1; 178(9):948-55. Epub ...

10. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels ...